HealthCare Global Enterprises Ltd (HCG):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:HealthCare Global Enterprises Ltd (HCG) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8043
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
HealthCare Global Enterprises Ltd (HCG), formerly Curie Centre of Oncology Private Ltd is a healthcare service provider that provides medical care and treatment services. The company provides services such as clinical laboratory services, diagnosis services, medical oncology services, radiation oncology services, surgical oncology services, and others. It offers other services such as integrated molecular pathology services, accurate diagnosis treatment services, 3 TMRI services, ABVS services, digital mammogram services, PET CT scanning services and accurate pathological diagnosis services, among others. HCG provides medical oncology services such as haemato oncology, paediatric oncology, breast health centre, preventive oncology, day care chemotherapy, patient counseling, integrative oncology services, and others. The company offers radiation oncology services such as brachytherapy, cyberknife robotic surgery, hyperthermia services, and others. It operates through a network of hospitals across India. HCG is headquartered in Bangalore, Karnataka, India.

HealthCare Global Enterprises Ltd (HCG) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
HealthCare Global Enterprises Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
HealthCare Global Enterprises Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
HealthCare Global Enterprises Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
HealthCare Global Enterprises Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
HealthCare Global Enterprises Ltd, Medical Devices Deals, 2012 to YTD 2018 9
HealthCare Global Enterprises Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
HealthCare Global Enterprises Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Private Equity 11
Temasek Invests US$27 Million In HealthCare Global Enterprises 11
Partnerships 12
HealthCare Global Enterprises Forms Joint Venture With Medica Synergie 12
Merger 13
HealthCare Global Enterprises Plans To Merge With Medica Synergie 13
Equity Offering 14
HealthCare Global Prices USD5.4 Million in Private Placement of Shares 14
Healthcare Global Enterprises Plans to Raise Funds through Rights Offering of Shares 15
HealthCare Global Enterprises Files Registration Statement for IPO for up to USD102 Million 16
Acquisition 17
HealthCare Global to Acquire 12% Stake in International Stemcell for USD0.1 Million 17
HealthCare Global Acquires Majority Stake In Bangalore Assisted Conception Centre 18
HealthCare Global Enterprises Ltd – Key Competitors 19
HealthCare Global Enterprises Ltd – Key Employees 20
HealthCare Global Enterprises Ltd – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
HealthCare Global Enterprises Ltd, Pharmaceuticals & Healthcare, Key Facts, 2018 2
HealthCare Global Enterprises Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
HealthCare Global Enterprises Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
HealthCare Global Enterprises Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
HealthCare Global Enterprises Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
HealthCare Global Enterprises Ltd, Medical Devices Deals, 2012 to YTD 2018 9
HealthCare Global Enterprises Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Temasek Invests US$27 Million In HealthCare Global Enterprises 11
HealthCare Global Enterprises Forms Joint Venture With Medica Synergie 12
HealthCare Global Enterprises Plans To Merge With Medica Synergie 13
HealthCare Global Prices USD5.4 Million in Private Placement of Shares 14
Healthcare Global Enterprises Plans to Raise Funds through Rights Offering of Shares 15
HealthCare Global Enterprises Files Registration Statement for IPO for up to USD102 Million 16
HealthCare Global to Acquire 12% Stake in International Stemcell for USD0.1 Million 17
HealthCare Global Acquires Majority Stake In Bangalore Assisted Conception Centre 18
HealthCare Global Enterprises Ltd, Key Competitors 19
HealthCare Global Enterprises Ltd, Key Employees 20
HealthCare Global Enterprises Ltd, Other Locations 21

List of Figures
HealthCare Global Enterprises Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
HealthCare Global Enterprises Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
HealthCare Global Enterprises Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
HealthCare Global Enterprises Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
HealthCare Global Enterprises Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
HealthCare Global Enterprises Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
HealthCare Global Enterprises Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
HealthCare Global Enterprises Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
HealthCare Global Enterprises Ltd, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[HealthCare Global Enterprises Ltd (HCG):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Norsk Hydro ASA:戦略・SWOT・企業財務分析
    Norsk Hydro ASA - Strategy, SWOT and Corporate Finance Report Summary Norsk Hydro ASA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • EDF Energy Holdings Ltd:電力:M&Aディール及び事業提携情報
    Summary EDF Energy Holdings Ltd (EDF Energy), a subsidiary of Electricite de France SA, is an energy utility and is one of the major producers of low carbon electricity in the UK. The company together with its subsidiaries carries out the generation, provision and supply of electricity and gas. It g …
  • Quanta Computer Inc (2382):企業の財務・戦略的SWOT分析
    Quanta Computer Inc (2382) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • La Plata Electric Association, Inc.:企業の発電所・SWOT分析2018
    La Plata Electric Association, Inc. - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information …
  • Dongfang Electric Corporation Ltd (1072):企業の財務・戦略的SWOT分析
    Dongfang Electric Corporation Ltd (1072) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Bank Rossiya
    Bank Rossiya - Strategy, SWOT and Corporate Finance Report Summary Bank Rossiya - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Zynerba Pharmaceuticals Inc (ZYNE):企業の財務・戦略的SWOT分析
    Summary Zynerba Pharmaceuticals Inc (Zynerba Pharmaceuticals), formerly AllTranz Inc, is a developer of next-generation synthetic cannabinoid therapeutics. The company provides pipeline product candidates such as ZYN002 and ZYN001. Its ZYN002 is a synthetic CBD, a non-psychoactive cannabinoid, formu …
  • Genuine Parts Company:戦略・SWOT・企業財務分析
    Genuine Parts Company - Strategy, SWOT and Corporate Finance Report Summary Genuine Parts Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • EPS Holdings Inc (4282):製薬・医療:M&Aディール及び事業提携情報
    Summary EPS Holdings Inc (EPS) is a pharmaceutical solutions provider to the healthcare industry. The company provides contract research organization, site management organization, contract sales organization, and other related services for pharmaceutical and medical device development. Its services …
  • Aurobindo Pharma Ltd (AUROPHARMA):製薬・医療:M&Aディール及び事業提携情報
    Summary Aurobindo Pharma Ltd (Aurobindo Pharma) is a pharmaceutical company which develops, manufactures and exports formulations and active pharmaceutical ingredients (API's). Its products portfolio includes active pharma ingredients, formulations, antibiotics, anti-retrovirals, anti- allergics, ga …
  • Royale Energy Inc (ROYL):企業の財務・戦略的SWOT分析
    Summary Royale Energy Inc (Royale Energy) is an independent exploration and production company. The company undertakes the business of acquisition, development, and marketing of oil and natural gas properties. Its business activities comprise acquisition of oil and gas interests and proved reserves, …
  • Euro Disney S.C.A.:戦略・SWOT・企業財務分析
    Euro Disney S.C.A. - Strategy, SWOT and Corporate Finance Report Summary Euro Disney S.C.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Taageer Finance Co (TFCI):企業の財務・戦略的SWOT分析
    Taageer Finance Co (TFCI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • US WorldMeds LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary US WorldMeds LLC (US WorldMeds) is a specialty pharmaceutical company that develops, licenses and markets healthcare products to improve lives of patients with challenging conditions and unmet medical needs. The company’s products comprise apokyn, myobloc and revonto. Its apokyn is used for …
  • FLSmidth & Co. A/S:企業の戦略・SWOT・財務情報
    FLSmidth & Co. A/S - Strategy, SWOT and Corporate Finance Report Summary FLSmidth & Co. A/S - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • CITGO Petroleum Corporation:企業の戦略・SWOT・財務情報
    CITGO Petroleum Corporation - Strategy, SWOT and Corporate Finance Report Summary CITGO Petroleum Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Shunfeng International Clean Energy Ltd (1165):電力:M&Aディール及び事業提携情報
    Summary Shunfeng International Clean Energy Ltd (Shunfeng International), formerly Shunfeng Photovoltaic International Ltd is a renewable energy company that manufactures and markets solar photovoltaic products. The company’s products include monocrystalline silicon solar cells, polycrystalline sili …
  • Allergy Therapeutics Plc (AGY):企業の財務・戦略的SWOT分析
    Allergy Therapeutics Plc (AGY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • ESAB Holdings Ltd:企業の戦略・SWOT・財務情報
    ESAB Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary ESAB Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Lantheus Medical Imaging Inc:製品パイプライン分析
    Summary Lantheus Medical Imaging Inc (Lantheus Medical), a subsidiary of Lantheus Holdings, Inc., develops, manufactures, and commercializes diagnostic imaging agents and products for the diagnosis of conditions that affect heart, brain, lungs and other organs using echocardiography and nuclear imag …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆